Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Geron Corp. -- Ignore unavailable to you. Want to Upgrade?

To: Lazlo Pierce who wrote (778)	1/16/1998 3:32:00 PM
From: BulbaMan	Read Replies (1) \| Respond to of 3578

Geron CEO, Ron Eastman, confirmed at the H&Q Biotech conference that 20/20 is scheduled to do a segment on Geron. It seemed to me he was confident the segment would be quite positive. Giving a preview of the show, Eastman relayed that as part of preparing the segment Hugh Downs asked Geron to measure the telomere length of some of his cells and compare it to the telomere length of his grandson's cells. The scientists measuring the telomeres, said Eastman, didn't know which cells belonged to Downs and which to his grandson. The result: Downs' (older) cells had much shorter telomeres. Other media news: Geron's chief scientist, Cal Harley was on NPR's "Science Friday" this morning and I thought he was quite informative. Also, I would bet the big news weeklys will have major coverage of the Science publication of the telomerase discovery.